{"data":[{"accessionNo":"0001104659-26-097049","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Baker Bros. Advisors (GP) LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":11443357,"percentOfClass":5.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0001104659-26-097049","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Julian C. Baker","reportingCik":null,"personType":"HC,IN","sharesOwned":11443357,"percentOfClass":5.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0001104659-26-097049","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Felix J. Baker","reportingCik":null,"personType":"HC,IN","sharesOwned":11443357,"percentOfClass":5.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0001104659-26-097049","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Baker Bros. Advisors LP","reportingCik":null,"personType":"IA,PN","sharesOwned":11443357,"percentOfClass":5.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Roberts, Jr., Thomas G.","reportingCik":null,"personType":"HC,IN","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Saito Edric C.","reportingCik":null,"personType":"HC,IN","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Short Daniel S.","reportingCik":null,"personType":"HC,IN","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Spokes, Andrew J. M.","reportingCik":null,"personType":"HC,IN","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Warren, John R.","reportingCik":null,"personType":"HC,IN","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Wehrly, Mark C.","reportingCik":null,"personType":"HC,IN","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Management, L.L.C.","reportingCik":null,"personType":"IA,OO","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Giauque, Nicolas","reportingCik":null,"personType":"HC,IN","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Kim, David T.","reportingCik":null,"personType":"HC,IN","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Linn, Michael G.","reportingCik":null,"personType":"HC,IN","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Luo Patrick (Cheng)","reportingCik":null,"personType":"HC,IN","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Husen, Avner A.","reportingCik":null,"personType":"HC,IN","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Dapice Joshua J.","reportingCik":null,"personType":"HC,IN","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Dreyfuss, Philip D.","reportingCik":null,"personType":"HC,IN","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Dunn Hannah E.","reportingCik":null,"personType":"HC,IN","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Gehani, Varun N.","reportingCik":null,"personType":"HC,IN","sharesOwned":13564149,"percentOfClass":6.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0001274173-26-000194","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001628171","issuerName":"REVOLUTION MEDICINES, INC.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"JANUS HENDERSON GROUP Ltd.","reportingCik":null,"personType":"HC","sharesOwned":10736145,"percentOfClass":5.1,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital F5 Master I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Institutional Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Institutional Partners II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Institutional Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Four Crossings Institutional Partners V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Offshore Investors II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital (AM) Investors, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Healthcare Partners Master, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Partners, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Institutional (GP) V, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon F5 (GP), L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000407","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Healthcare Partners (GP), L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0002012383-26-002874","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001628171","issuerName":"REVOLUTION MEDICINES INC","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":12201395,"percentOfClass":5.7,"filedAt":"2026-07-29","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0001274173-26-000119","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"REVOLUTION MEDICINES, INC.","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":9766496,"percentOfClass":4.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000102909-26-002203","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001628171","issuerName":"REVOLUTION Medicines Inc","ticker":"RVMD","cusip":"76155X100","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0001104659-26-016452","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Felix J. Baker","reportingCik":null,"personType":"HC,IN","sharesOwned":9455357,"percentOfClass":4.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0001104659-26-016452","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Julian C. Baker","reportingCik":null,"personType":"HC,IN","sharesOwned":9455357,"percentOfClass":4.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0001104659-26-016452","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Baker Bros. Advisors (GP) LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":9455357,"percentOfClass":4.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0001104659-26-016452","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Baker Bros. Advisors LP","reportingCik":null,"personType":"IA,PN","sharesOwned":9455357,"percentOfClass":4.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000902219-26-000036","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":6987639,"percentOfClass":3.6,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000902219-26-000036","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":6987639,"percentOfClass":3.6,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000902219-26-000036","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":6987639,"percentOfClass":3.6,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Wehrly, Mark C.","reportingCik":null,"personType":"IN","sharesOwned":14596149,"percentOfClass":7.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Dapice Joshua J.","reportingCik":null,"personType":"IN","sharesOwned":14596149,"percentOfClass":7.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Dreyfuss, Philip D.","reportingCik":null,"personType":"IN","sharesOwned":14596149,"percentOfClass":7.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Dunn Hannah E.","reportingCik":null,"personType":"IN","sharesOwned":14596149,"percentOfClass":7.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Gehani, Varun N.","reportingCik":null,"personType":"IN","sharesOwned":14596149,"percentOfClass":7.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Giauque, Nicolas","reportingCik":null,"personType":"IN","sharesOwned":14596149,"percentOfClass":7.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Husen, Avner A.","reportingCik":null,"personType":"IN","sharesOwned":14596149,"percentOfClass":7.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Kim, David T.","reportingCik":null,"personType":"IN","sharesOwned":14596149,"percentOfClass":7.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Linn, Michael G.","reportingCik":null,"personType":"IN","sharesOwned":14596149,"percentOfClass":7.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Luo Patrick (Cheng)","reportingCik":null,"personType":"IN","sharesOwned":14596149,"percentOfClass":7.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Roberts, Jr., Thomas G.","reportingCik":null,"personType":"IN","sharesOwned":14596149,"percentOfClass":7.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Saito Edric C.","reportingCik":null,"personType":"IN","sharesOwned":14596149,"percentOfClass":7.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Short Daniel S.","reportingCik":null,"personType":"IN","sharesOwned":14596149,"percentOfClass":7.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Spokes, Andrew J. M.","reportingCik":null,"personType":"IN","sharesOwned":14596149,"percentOfClass":7.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Warren, John R.","reportingCik":null,"personType":"IN","sharesOwned":14596149,"percentOfClass":7.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Partners, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":14225683,"percentOfClass":7.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Healthcare Partners Master, L.P.","reportingCik":null,"personType":"PN","sharesOwned":8420065,"percentOfClass":4.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Healthcare Partners (GP), L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":8420065,"percentOfClass":4.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Offshore Investors II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2482796,"percentOfClass":1.3,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Institutional Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1377579,"percentOfClass":0.7,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1057562,"percentOfClass":0.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Institutional Partners II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":332755,"percentOfClass":0.2,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital F5 Master I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":370466,"percentOfClass":0.2,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon F5 (GP), L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":370466,"percentOfClass":0.2,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Four Crossings Institutional Partners V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":238987,"percentOfClass":0.1,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Institutional (GP) V, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":238987,"percentOfClass":0.1,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital (AM) Investors, L.P.","reportingCik":null,"personType":"PN","sharesOwned":151742,"percentOfClass":0.1,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Institutional Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":164197,"percentOfClass":0.1,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Fried, Richard B","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Patel, Rajiv A.","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000908834-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"Revolution Medicines, Inc.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Seybold, William","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0001274173-25-000308","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001628171","issuerName":"REVOLUTION MEDICINES, INC.","ticker":"RVMD","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":11356054,"percentOfClass":6.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000315066-25-002809","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001628171","issuerName":"REVOLUTION MEDICINES INC","ticker":"RVMD","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":9401686.7,"percentOfClass":5,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"},{"accessionNo":"0000315066-25-002809","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001628171","issuerName":"REVOLUTION MEDICINES INC","ticker":"RVMD","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":9401686.7,"percentOfClass":5,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd"}],"updatedAt":"2026-10-29T07:10:21.132Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/rvmd","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}